UB experts weigh in on DEA's reclassification of cannabis |

BUFFALO — The U.S. Drug Enforcement Administration’s move to reclassify cannabis from a Schedule I to a Schedule III substance has broad implications, paving the way for more informed research

Related Keywords

Boston , Massachusetts , United States , Los Angeles , Robert Silverman , R Lorraine Collins , National Institute On Drug Abuse , Cannabinoid Research , Ub College Of Arts , Ub School Of Architecture , Us Drug Enforcement Administration , Ub Center , University At Buffalo Center , Ub School Of Public Health , Health Professions , Enforcement Administration , Public Health , Rebecca Ashare , National Institute , Drug Abuse ,